Filed: 12/27/2023ACC: 0001104659-23-129773
Officer· EVP Clinical Development
Since Jun 2021
-949.92K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
5
Total transactions
949.92K disposed
Non-Derivative Transactions0
No non-derivative transactions reported
Derivative Transactions5
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
125.55K shares
Shares
−125.55K
Strike price
6.97
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
461.25K shares
Shares
−461.25K
Strike price
8.47
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
213.30K shares
Shares
−213.30K
Strike price
8.13
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
13.77K shares
Shares
−13.77K
Strike price
7.91
Held after
0.00
Exercisable
—
12/27/2023
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
136.06K shares
Shares
−136.06K
Strike price
6.78
Held after
0.00
Exercisable
—
12/27/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock125.55K shares | 12/27/2023 | D · Disposition | −125.55K | 6.97 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock461.25K shares | 12/27/2023 | D · Disposition | −461.25K | 8.47 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock213.30K shares | 12/27/2023 | D · Disposition | −213.30K | 8.13 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock13.77K shares | 12/27/2023 | D · Disposition | −13.77K | 7.91 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock136.06K shares | 12/27/2023 | D · Disposition | −136.06K | 6.78 | — | 0.00 |